ULK1 and neoplasm: To assess whether the pharmacological inhibition of autophagy could replicate the effects observed with genetic autophagy inhibition, we utilized a CT26 subcutaneous tumor model treated with SBI-0206965, a small-molecule ULK1 inhibitor whose safety has been well-documented in a previous mouse study 21.